Cargando…
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis
Background: Leishmaniases are neglected diseases caused by infection with Leishmania parasites and there are no human vaccines in use routinely. The purpose of this study was to examine the immunogenicity of ChimeraT, a novel synthetic recombinant vaccine against visceral leishmaniasis (VL), incorpo...
Autores principales: | Lage, Daniela P., Ribeiro, Patrícia A.F., Dias, Daniel S., Mendonça, Débora V.C., Ramos, Fernanda F., Carvalho, Lívia M., Steiner, Bethina T., Tavares, Grasiele S.V., Martins, Vívian T., Machado, Amanda S., Oliveira-da-Silva, João A., Santos, Thaís T.O., Freitas, Camila S., Oliveira, Jamil S., Roatt, Bruno M., Machado-de-Ávila, Ricardo A., Humbert, Maria V., Christodoulides, Myron, Coelho, Eduardo A.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349940/ https://www.ncbi.nlm.nih.gov/pubmed/32526867 http://dx.doi.org/10.3390/vaccines8020289 |
Ejemplares similares
-
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection
por: Lage, Daniela P., et al.
Publicado: (2020) -
A clioquinol-containing Pluronic(®) F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model
por: Tavares, Grasiele S.V., et al.
Publicado: (2020) -
In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis
por: Freitas, Camila S., et al.
Publicado: (2021) -
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection
por: Galvani, Nathalia C., et al.
Publicado: (2021) -
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis
por: Vale, Danniele L., et al.
Publicado: (2023)